Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PAX5
|
ENSG00000196092.14 | paired box 5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PAX5 | hg38_v1_chr9_-_37034261_37034273 | 0.82 | 1.2e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_105856183 | 7.98 |
ENST00000637539.2
ENST00000390559.6 |
IGHM
|
immunoglobulin heavy constant mu |
chr22_+_22792485 | 6.93 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr22_+_22357739 | 6.30 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr22_+_22409755 | 6.18 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
chr22_-_37486357 | 5.90 |
ENST00000356998.8
ENST00000416983.7 ENST00000424765.2 |
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr22_+_22822658 | 5.61 |
ENST00000620395.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr14_-_106511856 | 5.35 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr11_+_61102465 | 5.33 |
ENST00000347785.8
ENST00000544014.1 |
CD5
|
CD5 molecule |
chr2_-_89027700 | 5.15 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr19_+_49335396 | 5.07 |
ENST00000598095.5
ENST00000426897.6 ENST00000323906.9 ENST00000535669.6 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr22_+_22030934 | 4.85 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr14_-_106715166 | 4.79 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr14_-_105708627 | 4.76 |
ENST00000641837.1
ENST00000390547.3 |
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr22_+_22880706 | 4.69 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr22_+_22758698 | 4.57 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr22_+_22922594 | 4.39 |
ENST00000390331.3
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr2_-_89320146 | 4.34 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 |
chr2_-_89100352 | 4.28 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr22_+_22343185 | 4.27 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
chr22_+_22734577 | 4.16 |
ENST00000390310.3
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr2_+_90159840 | 4.05 |
ENST00000377032.5
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr14_-_106154113 | 4.04 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
chr2_-_89177160 | 4.02 |
ENST00000484817.1
|
IGKV2-24
|
immunoglobulin kappa variable 2-24 |
chr2_-_89213917 | 3.98 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr22_+_22818994 | 3.95 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 |
chr14_-_106762576 | 3.95 |
ENST00000624687.1
|
IGHV1-69D
|
immunoglobulin heavy variable 1-69D |
chr22_+_22375984 | 3.84 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr10_+_79610932 | 3.82 |
ENST00000428376.6
ENST00000398636.8 ENST00000419470.6 ENST00000429958.5 |
SFTPA1
|
surfactant protein A1 |
chr2_-_88979016 | 3.77 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr2_+_90100235 | 3.75 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr22_+_22697789 | 3.69 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr16_+_85908988 | 3.69 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
chr22_-_41926791 | 3.66 |
ENST00000291232.5
|
TNFRSF13C
|
TNF receptor superfamily member 13C |
chr17_-_75844334 | 3.66 |
ENST00000592386.5
ENST00000412096.6 ENST00000586147.1 ENST00000207549.9 |
UNC13D
|
unc-13 homolog D |
chr3_+_32951636 | 3.53 |
ENST00000330953.6
|
CCR4
|
C-C motif chemokine receptor 4 |
chr14_-_106277039 | 3.48 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
chr1_+_160796157 | 3.42 |
ENST00000263285.11
ENST00000368039.2 |
LY9
|
lymphocyte antigen 9 |
chr1_+_32251239 | 3.41 |
ENST00000373564.7
ENST00000482949.5 ENST00000336890.10 ENST00000495610.6 |
LCK
|
LCK proto-oncogene, Src family tyrosine kinase |
chr22_+_22162155 | 3.40 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
chr11_+_60455839 | 3.40 |
ENST00000532491.5
ENST00000532073.5 ENST00000345732.9 ENST00000534668.6 ENST00000528313.1 ENST00000533306.6 ENST00000674194.1 |
MS4A1
|
membrane spanning 4-domains A1 |
chr2_+_89862438 | 3.35 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr1_-_161631032 | 3.28 |
ENST00000534776.1
ENST00000613418.4 ENST00000614870.4 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
chr22_+_22887780 | 3.28 |
ENST00000532223.2
ENST00000526893.6 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda like polypeptide 5 |
chr22_+_22380766 | 3.25 |
ENST00000390297.3
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr7_+_142300924 | 3.16 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
chr19_-_7700074 | 3.15 |
ENST00000593418.1
|
FCER2
|
Fc fragment of IgE receptor II |
chr2_+_90004792 | 3.07 |
ENST00000462693.1
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional) |
chr19_-_54313074 | 3.07 |
ENST00000486742.2
ENST00000432233.8 |
LILRA5
|
leukocyte immunoglobulin like receptor A5 |
chr12_-_53207271 | 3.05 |
ENST00000552972.5
ENST00000422257.7 |
ITGB7
|
integrin subunit beta 7 |
chr1_+_171557845 | 3.04 |
ENST00000644916.1
|
PRRC2C
|
proline rich coiled-coil 2C |
chr14_-_105588322 | 3.02 |
ENST00000497872.4
ENST00000390539.2 |
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr22_+_22098683 | 3.00 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr22_+_22431949 | 2.99 |
ENST00000390301.3
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr11_+_65879791 | 2.98 |
ENST00000528419.6
ENST00000307886.8 ENST00000526034.2 ENST00000679584.1 ENST00000680443.1 ENST00000680670.1 |
CTSW
|
cathepsin W |
chr2_-_88947820 | 2.95 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr7_+_142349135 | 2.95 |
ENST00000634383.1
|
TRBV6-2
|
T cell receptor beta variable 6-2 |
chr8_+_11494367 | 2.94 |
ENST00000259089.9
ENST00000529894.1 |
BLK
|
BLK proto-oncogene, Src family tyrosine kinase |
chr7_+_142563730 | 2.88 |
ENST00000617347.1
|
TRBV12-4
|
T cell receptor beta variable 12-4 |
chr8_+_22161788 | 2.87 |
ENST00000521315.5
ENST00000437090.6 ENST00000679463.1 ENST00000520605.5 ENST00000522109.5 ENST00000524255.5 ENST00000523296.1 |
SFTPC
|
surfactant protein C |
chr5_-_39219555 | 2.85 |
ENST00000512982.4
ENST00000351578.12 ENST00000509072.5 ENST00000504542.1 ENST00000506557.5 |
FYB1
|
FYN binding protein 1 |
chr2_-_89085787 | 2.82 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr6_-_31582415 | 2.82 |
ENST00000429299.3
ENST00000446745.2 |
LTB
|
lymphotoxin beta |
chr2_+_89947508 | 2.80 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chr22_+_22686724 | 2.78 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
chr11_+_117986386 | 2.78 |
ENST00000227752.8
|
IL10RA
|
interleukin 10 receptor subunit alpha |
chr14_-_106579223 | 2.75 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
chr14_-_106185387 | 2.74 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
chr1_+_32274111 | 2.74 |
ENST00000619559.4
ENST00000461712.6 ENST00000373562.7 ENST00000477031.6 ENST00000373557.6 ENST00000333070.4 |
LCK
|
LCK proto-oncogene, Src family tyrosine kinase |
chr15_-_22160868 | 2.74 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr22_-_23754376 | 2.73 |
ENST00000398465.3
ENST00000248948.4 |
VPREB3
|
V-set pre-B cell surrogate light chain 3 |
chr19_+_3178756 | 2.73 |
ENST00000246115.5
|
S1PR4
|
sphingosine-1-phosphate receptor 4 |
chr14_-_105987068 | 2.70 |
ENST00000390594.3
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
chr14_-_106062670 | 2.68 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
chr2_-_89268506 | 2.67 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
chr15_-_40307825 | 2.65 |
ENST00000456256.6
ENST00000557821.5 |
PLCB2
|
phospholipase C beta 2 |
chr1_-_160862700 | 2.62 |
ENST00000322302.7
ENST00000368033.7 |
CD244
|
CD244 molecule |
chr14_+_21997531 | 2.60 |
ENST00000390445.2
|
TRAV17
|
T cell receptor alpha variable 17 |
chr1_-_160862880 | 2.59 |
ENST00000368034.9
|
CD244
|
CD244 molecule |
chr14_-_106360320 | 2.58 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
chr15_-_40307910 | 2.58 |
ENST00000543785.3
ENST00000260402.8 |
PLCB2
|
phospholipase C beta 2 |
chr20_+_47501929 | 2.57 |
ENST00000371997.3
|
NCOA3
|
nuclear receptor coactivator 3 |
chr1_-_160523204 | 2.54 |
ENST00000368055.1
ENST00000368057.8 ENST00000368059.7 |
SLAMF6
|
SLAM family member 6 |
chr2_-_89143133 | 2.54 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr2_+_89913982 | 2.51 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
chr2_-_89245596 | 2.50 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
chr1_-_159076742 | 2.49 |
ENST00000368130.9
|
AIM2
|
absent in melanoma 2 |
chr1_-_161631152 | 2.49 |
ENST00000421702.3
ENST00000650385.1 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
chr14_-_105845677 | 2.49 |
ENST00000390556.6
|
IGHD
|
immunoglobulin heavy constant delta |
chr7_+_142791635 | 2.48 |
ENST00000633705.1
|
TRBC1
|
T cell receptor beta constant 1 |
chr19_-_7732160 | 2.48 |
ENST00000676742.1
ENST00000678118.1 ENST00000328853.10 |
CLEC4G
|
C-type lectin domain family 4 member G |
chr5_+_131264043 | 2.47 |
ENST00000505065.2
ENST00000503291.5 ENST00000360515.7 |
CDC42SE2
|
CDC42 small effector 2 |
chr20_+_47501875 | 2.46 |
ENST00000371998.8
ENST00000372004.7 |
NCOA3
|
nuclear receptor coactivator 3 |
chr11_+_67404077 | 2.45 |
ENST00000542590.2
ENST00000312390.9 |
TBC1D10C
|
TBC1 domain family member 10C |
chr14_-_22819721 | 2.44 |
ENST00000554517.5
ENST00000285850.11 ENST00000397529.6 ENST00000555702.5 |
SLC7A7
|
solute carrier family 7 member 7 |
chr3_+_196639684 | 2.44 |
ENST00000328557.5
|
NRROS
|
negative regulator of reactive oxygen species |
chr15_-_21718245 | 2.43 |
ENST00000630556.1
|
ENSG00000281179.1
|
novel gene identicle to IGHV1OR15-1 |
chr12_+_69348372 | 2.42 |
ENST00000261267.7
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
chr14_-_106130061 | 2.41 |
ENST00000390602.3
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
chr16_-_3577375 | 2.41 |
ENST00000359128.10
|
NLRC3
|
NLR family CARD domain containing 3 |
chr7_+_74209989 | 2.39 |
ENST00000361082.7
ENST00000275635.11 ENST00000460943.6 ENST00000470709.1 |
LAT2
|
linker for activation of T cells family member 2 |
chr16_-_726431 | 2.38 |
ENST00000345165.10
ENST00000650995.1 ENST00000293889.10 |
CCDC78
|
coiled-coil domain containing 78 |
chr11_-_64744102 | 2.37 |
ENST00000431822.5
ENST00000394432.8 ENST00000377486.7 |
RASGRP2
|
RAS guanyl releasing protein 2 |
chr11_+_72135718 | 2.36 |
ENST00000611028.3
ENST00000546166.1 ENST00000442948.3 |
FOLR3
|
folate receptor gamma |
chrX_-_71111448 | 2.36 |
ENST00000456850.6
ENST00000473378.1 ENST00000374202.7 ENST00000374188.7 |
IL2RG
|
interleukin 2 receptor subunit gamma |
chr12_-_54295748 | 2.35 |
ENST00000540264.2
ENST00000312156.8 |
NFE2
|
nuclear factor, erythroid 2 |
chr14_-_106737547 | 2.35 |
ENST00000632209.1
|
IGHV1-69-2
|
immunoglobulin heavy variable 1-69-2 |
chr1_+_110871182 | 2.34 |
ENST00000648608.1
|
CD53
|
CD53 molecule |
chr14_+_21852457 | 2.34 |
ENST00000390435.1
|
TRAV8-3
|
T cell receptor alpha variable 8-3 |
chr14_-_106658251 | 2.34 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
chr1_-_162023826 | 2.34 |
ENST00000294794.8
|
OLFML2B
|
olfactomedin like 2B |
chr19_-_15464525 | 2.33 |
ENST00000343625.12
|
RASAL3
|
RAS protein activator like 3 |
chr10_-_70602759 | 2.32 |
ENST00000373209.2
|
PRF1
|
perforin 1 |
chr12_-_53207241 | 2.31 |
ENST00000267082.10
ENST00000549086.2 |
ITGB7
|
integrin subunit beta 7 |
chr7_+_142800957 | 2.30 |
ENST00000466254.1
|
TRBC2
|
T cell receptor beta constant 2 |
chr2_-_89222461 | 2.30 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
chr19_+_54630960 | 2.28 |
ENST00000396317.5
ENST00000396315.5 |
LILRB1
|
leukocyte immunoglobulin like receptor B1 |
chr16_+_28931942 | 2.26 |
ENST00000324662.8
ENST00000538922.8 |
CD19
|
CD19 molecule |
chr6_-_30684744 | 2.26 |
ENST00000615892.4
|
PPP1R18
|
protein phosphatase 1 regulatory subunit 18 |
chr10_-_70602731 | 2.26 |
ENST00000441259.2
|
PRF1
|
perforin 1 |
chr6_-_32666648 | 2.25 |
ENST00000399082.7
ENST00000399079.7 ENST00000374943.8 ENST00000434651.6 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
chr2_-_89040745 | 2.24 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr14_-_106675544 | 2.24 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
chr7_-_38363476 | 2.23 |
ENST00000426402.2
|
TRGV2
|
T cell receptor gamma variable 2 |
chr11_+_118344318 | 2.23 |
ENST00000392883.6
ENST00000532917.3 ENST00000528540.5 |
CD3G
|
CD3g molecule |
chr19_-_39335999 | 2.22 |
ENST00000602185.5
ENST00000598034.5 ENST00000601387.5 ENST00000595636.1 ENST00000253054.12 ENST00000594700.5 ENST00000597595.6 |
GMFG
|
glia maturation factor gamma |
chr11_-_111379268 | 2.21 |
ENST00000393067.8
|
POU2AF1
|
POU class 2 homeobox associating factor 1 |
chr2_+_90220727 | 2.20 |
ENST00000471857.2
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr22_+_22900976 | 2.19 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 |
chr2_-_86790825 | 2.19 |
ENST00000409781.1
ENST00000352580.7 |
CD8A
|
CD8a molecule |
chr14_-_106593319 | 2.19 |
ENST00000390627.3
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
chr10_+_69088096 | 2.17 |
ENST00000242465.4
|
SRGN
|
serglycin |
chr19_-_54281082 | 2.17 |
ENST00000314446.10
|
LILRB2
|
leukocyte immunoglobulin like receptor B2 |
chr2_-_89117844 | 2.16 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr22_+_22771791 | 2.16 |
ENST00000390313.3
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
chr2_-_86790900 | 2.15 |
ENST00000283635.8
|
CD8A
|
CD8a molecule |
chr22_+_22369601 | 2.15 |
ENST00000390295.3
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 |
chr8_+_22161655 | 2.15 |
ENST00000318561.7
|
SFTPC
|
surfactant protein C |
chr22_+_22327298 | 2.14 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr12_-_51324652 | 2.13 |
ENST00000544402.5
|
BIN2
|
bridging integrator 2 |
chr10_-_133276855 | 2.10 |
ENST00000486609.1
ENST00000445355.8 ENST00000485491.6 |
ADAM8
|
ADAM metallopeptidase domain 8 |
chr6_-_42048648 | 2.10 |
ENST00000502771.1
ENST00000508143.5 ENST00000514588.1 ENST00000510503.5 |
CCND3
|
cyclin D3 |
chr19_+_7677082 | 2.09 |
ENST00000597445.1
|
MCEMP1
|
mast cell expressed membrane protein 1 |
chr16_+_30182969 | 2.08 |
ENST00000561815.5
|
CORO1A
|
coronin 1A |
chr10_-_70602687 | 2.07 |
ENST00000638674.1
|
PRF1
|
perforin 1 |
chr14_-_106301848 | 2.04 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
chr22_+_36913620 | 2.04 |
ENST00000403662.8
ENST00000262825.9 |
CSF2RB
|
colony stimulating factor 2 receptor subunit beta |
chr20_+_32052192 | 2.03 |
ENST00000375862.7
ENST00000629881.2 ENST00000375852.5 ENST00000520553.5 ENST00000518730.5 |
HCK
|
HCK proto-oncogene, Src family tyrosine kinase |
chr5_-_176899332 | 2.02 |
ENST00000292432.10
|
HK3
|
hexokinase 3 |
chr7_+_142720652 | 2.02 |
ENST00000390400.2
|
TRBV28
|
T cell receptor beta variable 28 |
chr16_+_30182795 | 2.01 |
ENST00000563778.5
|
CORO1A
|
coronin 1A |
chr6_-_24910695 | 2.01 |
ENST00000643623.1
ENST00000538035.6 ENST00000647136.1 |
RIPOR2
|
RHO family interacting cell polarization regulator 2 |
chr5_-_1523900 | 2.00 |
ENST00000283415.4
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1 |
chr19_+_48874318 | 2.00 |
ENST00000600406.1
|
PPP1R15A
|
protein phosphatase 1 regulatory subunit 15A |
chr6_+_31498136 | 1.99 |
ENST00000252229.7
|
MICB
|
MHC class I polypeptide-related sequence B |
chr19_+_41877267 | 1.96 |
ENST00000221972.8
ENST00000597454.1 ENST00000444740.2 |
CD79A
|
CD79a molecule |
chr12_-_51324164 | 1.94 |
ENST00000615107.6
|
BIN2
|
bridging integrator 2 |
chr22_+_22906342 | 1.91 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr7_+_142391884 | 1.90 |
ENST00000390363.2
|
TRBV9
|
T cell receptor beta variable 9 |
chr19_+_18173148 | 1.90 |
ENST00000597802.2
|
IFI30
|
IFI30 lysosomal thiol reductase |
chr11_-_47378494 | 1.90 |
ENST00000533030.1
|
SPI1
|
Spi-1 proto-oncogene |
chr1_+_12166978 | 1.90 |
ENST00000376259.7
ENST00000536782.2 |
TNFRSF1B
|
TNF receptor superfamily member 1B |
chr6_-_24911029 | 1.89 |
ENST00000259698.9
ENST00000644621.1 ENST00000644411.1 |
RIPOR2
|
RHO family interacting cell polarization regulator 2 |
chr6_+_137871208 | 1.89 |
ENST00000614035.4
ENST00000621150.3 ENST00000619035.4 ENST00000615468.4 ENST00000620204.3 |
TNFAIP3
|
TNF alpha induced protein 3 |
chr1_+_161706949 | 1.89 |
ENST00000350710.3
ENST00000367949.6 ENST00000367959.6 ENST00000540521.5 ENST00000546024.5 ENST00000674251.1 ENST00000674323.1 |
FCRLA
|
Fc receptor like A |
chr15_+_81196871 | 1.87 |
ENST00000559383.5
ENST00000394660.6 ENST00000683961.1 |
IL16
|
interleukin 16 |
chr5_+_55102635 | 1.86 |
ENST00000274306.7
|
GZMA
|
granzyme A |
chr17_+_78130759 | 1.86 |
ENST00000590426.1
ENST00000318430.10 ENST00000590799.5 ENST00000589691.1 |
TMC8
|
transmembrane channel like 8 |
chr22_+_37282464 | 1.85 |
ENST00000402997.5
ENST00000405206.3 ENST00000248901.11 |
CYTH4
|
cytohesin 4 |
chr10_-_79560386 | 1.85 |
ENST00000372327.9
ENST00000417041.1 ENST00000640627.1 ENST00000372325.7 |
SFTPA2
|
surfactant protein A2 |
chr3_+_46370854 | 1.85 |
ENST00000292303.4
|
CCR5
|
C-C motif chemokine receptor 5 |
chr3_+_32391841 | 1.84 |
ENST00000334983.10
|
CMTM7
|
CKLF like MARVEL transmembrane domain containing 7 |
chr5_-_139389905 | 1.84 |
ENST00000302125.9
|
MZB1
|
marginal zone B and B1 cell specific protein |
chr11_+_35139162 | 1.84 |
ENST00000415148.6
ENST00000263398.11 ENST00000428726.8 ENST00000526669.6 ENST00000433892.6 ENST00000525211.6 ENST00000278386.10 ENST00000434472.6 ENST00000352818.8 ENST00000442151.6 |
CD44
|
CD44 molecule (Indian blood group) |
chr11_-_47378527 | 1.83 |
ENST00000378538.8
|
SPI1
|
Spi-1 proto-oncogene |
chr15_+_64841873 | 1.82 |
ENST00000616065.4
ENST00000323544.5 |
PLEKHO2
|
pleckstrin homology domain containing O2 |
chr16_-_29745951 | 1.82 |
ENST00000329410.4
|
C16orf54
|
chromosome 16 open reading frame 54 |
chr19_+_39406831 | 1.81 |
ENST00000597629.3
ENST00000594442.2 ENST00000594045.2 |
ZFP36
|
ZFP36 ring finger protein |
chr17_-_64413774 | 1.81 |
ENST00000564866.5
|
PECAM1
|
platelet and endothelial cell adhesion molecule 1 |
chr1_+_206507546 | 1.80 |
ENST00000580449.5
ENST00000581503.6 |
RASSF5
|
Ras association domain family member 5 |
chr2_-_89297785 | 1.80 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
chr13_-_99307387 | 1.79 |
ENST00000376414.5
|
GPR183
|
G protein-coupled receptor 183 |
chr16_-_30382805 | 1.79 |
ENST00000321367.7
ENST00000652617.1 |
SEPTIN1
|
septin 1 |
chr14_-_106117159 | 1.78 |
ENST00000390601.3
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 |
chr15_+_80779343 | 1.78 |
ENST00000220244.7
ENST00000394685.8 ENST00000356249.9 |
CEMIP
|
cell migration inducing hyaluronidase 1 |
chr11_+_1876467 | 1.78 |
ENST00000432093.1
|
LSP1
|
lymphocyte specific protein 1 |
chr17_+_7336502 | 1.78 |
ENST00000158762.8
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr19_+_544034 | 1.78 |
ENST00000592501.5
ENST00000264553.6 |
GZMM
|
granzyme M |
chr2_-_218166951 | 1.78 |
ENST00000295683.3
|
CXCR1
|
C-X-C motif chemokine receptor 1 |
chr1_+_206507520 | 1.78 |
ENST00000579436.7
|
RASSF5
|
Ras association domain family member 5 |
chr1_-_27635176 | 1.77 |
ENST00000374005.8
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase |
chr19_-_54281145 | 1.77 |
ENST00000434421.5
ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin like receptor B2 |
chr12_-_51324138 | 1.76 |
ENST00000452142.7
|
BIN2
|
bridging integrator 2 |
chr7_+_116222804 | 1.76 |
ENST00000393481.6
|
TES
|
testin LIM domain protein |
chr17_+_36103819 | 1.76 |
ENST00000615863.2
ENST00000621626.1 |
CCL4
|
C-C motif chemokine ligand 4 |
chr1_+_24502830 | 1.75 |
ENST00000374395.9
|
RCAN3
|
RCAN family member 3 |
chr12_+_6444932 | 1.74 |
ENST00000266557.4
|
CD27
|
CD27 molecule |
chr14_-_106349792 | 1.73 |
ENST00000438142.3
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
chr14_+_21868822 | 1.73 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
chr17_-_48430205 | 1.73 |
ENST00000336915.11
ENST00000584924.5 |
SKAP1
|
src kinase associated phosphoprotein 1 |
chrX_-_101386166 | 1.73 |
ENST00000308731.8
ENST00000372880.5 |
BTK
|
Bruton tyrosine kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.6 | GO:0071661 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
1.8 | 5.5 | GO:0002432 | granuloma formation(GO:0002432) |
1.8 | 3.6 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
1.3 | 6.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
1.3 | 6.5 | GO:0002357 | defense response to tumor cell(GO:0002357) |
1.2 | 199.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.2 | 3.5 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
1.1 | 4.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.1 | 8.5 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
1.1 | 3.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
1.1 | 3.2 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
1.0 | 5.2 | GO:0032796 | uropod organization(GO:0032796) |
1.0 | 2.9 | GO:0002436 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
0.9 | 6.6 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.9 | 5.6 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.9 | 2.8 | GO:0002339 | B cell selection(GO:0002339) |
0.9 | 3.7 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.9 | 4.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.9 | 6.9 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.8 | 5.0 | GO:0035624 | receptor transactivation(GO:0035624) |
0.8 | 3.3 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.8 | 2.5 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.8 | 0.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.8 | 0.8 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.8 | 3.2 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.8 | 2.4 | GO:2000469 | regulation of thioredoxin peroxidase activity(GO:1903123) negative regulation of thioredoxin peroxidase activity(GO:1903124) negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation(GO:1903125) Wnt signalosome assembly(GO:1904887) negative regulation of peroxidase activity(GO:2000469) |
0.8 | 1.5 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.8 | 3.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.7 | 2.2 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.7 | 2.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.7 | 2.9 | GO:0052360 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.7 | 2.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 3.5 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.7 | 2.8 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.7 | 2.1 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
0.7 | 1.4 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.7 | 4.7 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.7 | 2.0 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.6 | 4.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.6 | 5.8 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.6 | 2.5 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.6 | 1.9 | GO:0015734 | taurine transport(GO:0015734) |
0.6 | 3.7 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.6 | 3.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.6 | 8.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.6 | 8.9 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.6 | 3.0 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.6 | 2.4 | GO:2000703 | regulation of cell proliferation involved in mesonephros development(GO:2000606) negative regulation of cell proliferation involved in mesonephros development(GO:2000607) fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000699) glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000701) regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000702) negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000703) regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000733) negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000734) |
0.6 | 2.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.6 | 2.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) |
0.6 | 1.7 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.6 | 0.6 | GO:0032701 | negative regulation of interleukin-18 production(GO:0032701) |
0.6 | 6.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.6 | 1.7 | GO:0042946 | glucoside transport(GO:0042946) |
0.6 | 4.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.5 | 1.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 2.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.5 | 4.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.5 | 4.1 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.5 | 3.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 3.0 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 1.0 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
0.5 | 5.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.5 | 1.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 0.5 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.5 | 4.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.5 | 1.9 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.5 | 1.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.5 | 2.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.5 | 1.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.5 | 1.9 | GO:0050823 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.5 | 9.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 1.8 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 1.8 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.4 | 2.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.4 | 3.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.4 | 1.8 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.4 | 0.4 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.4 | 1.3 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 1.3 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.4 | 1.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.4 | 1.8 | GO:2000753 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
0.4 | 3.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.4 | 0.4 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.4 | 1.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.4 | 1.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.4 | 86.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 7.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 0.4 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
0.4 | 2.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.4 | 3.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.4 | 1.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 1.2 | GO:0071810 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.4 | 2.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.4 | 2.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 3.5 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.4 | 3.9 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.4 | 1.5 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.4 | 1.1 | GO:2000407 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.4 | 1.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.4 | 1.1 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.4 | 1.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.4 | 1.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 0.7 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.4 | 0.7 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.4 | 5.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 0.7 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.4 | 1.8 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.4 | 2.2 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.4 | 1.1 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.4 | 1.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 1.0 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.3 | 2.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 2.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.3 | 1.4 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.3 | 1.0 | GO:0043382 | interleukin-23-mediated signaling pathway(GO:0038155) positive regulation of memory T cell differentiation(GO:0043382) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.3 | 1.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.3 | 16.8 | GO:0071800 | podosome assembly(GO:0071800) |
0.3 | 5.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.3 | 2.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 1.3 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
0.3 | 2.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.3 | 1.3 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.3 | 2.2 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.3 | 1.0 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.3 | 2.8 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 0.6 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 0.6 | GO:0044416 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.3 | 0.3 | GO:0045401 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
0.3 | 0.9 | GO:0030221 | basophil differentiation(GO:0030221) |
0.3 | 0.6 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.3 | 1.2 | GO:1902724 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.3 | 7.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.3 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 6.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 4.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.3 | 0.9 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.3 | 0.9 | GO:0071529 | cementum mineralization(GO:0071529) |
0.3 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 2.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.9 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.3 | 2.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 0.8 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.3 | 0.8 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.3 | 1.7 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.3 | 3.9 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 1.4 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.3 | 1.9 | GO:0014900 | muscle hyperplasia(GO:0014900) |
0.3 | 1.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.3 | 1.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 1.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 0.3 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.3 | 0.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 2.4 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.3 | 1.4 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 1.9 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.3 | 2.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.8 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 1.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.3 | 0.5 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.3 | 0.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 6.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 1.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.3 | 1.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.3 | 1.0 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.3 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 1.0 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.2 | 0.7 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 0.5 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 2.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 4.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.7 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.2 | 1.7 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 2.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.2 | 1.4 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 1.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 4.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 2.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 0.7 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.2 | 1.9 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 2.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 4.2 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.7 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
0.2 | 4.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.9 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.2 | 3.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 1.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.2 | 0.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.7 | GO:1990579 | protein trans-autophosphorylation(GO:0036290) peptidyl-serine trans-autophosphorylation(GO:1990579) |
0.2 | 0.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 4.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 0.7 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.2 | 0.4 | GO:0072679 | thymocyte migration(GO:0072679) |
0.2 | 3.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.7 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.2 | 5.4 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.2 | 17.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 1.0 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.2 | 1.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.6 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.2 | 1.0 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.2 | 0.2 | GO:0060309 | elastin catabolic process(GO:0060309) |
0.2 | 3.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.2 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.2 | 0.6 | GO:1904826 | phenotypic switching(GO:0036166) regulation of phenotypic switching by transcription from RNA polymerase II promoter(GO:0100057) regulation of phenotypic switching(GO:1900239) regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
0.2 | 1.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.6 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 0.2 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.2 | 1.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 0.6 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.2 | 0.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 3.0 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 3.0 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.2 | 0.6 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.2 | 1.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 1.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 0.8 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.2 | 1.8 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 1.0 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.2 | 1.0 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.2 | 0.8 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.2 | 0.2 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 1.2 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.2 | 1.5 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.2 | 1.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.4 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
0.2 | 0.4 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
0.2 | 2.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 1.1 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.2 | 0.7 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.2 | 0.4 | GO:0060197 | cloacal septation(GO:0060197) |
0.2 | 1.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 14.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.5 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 2.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 0.5 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.2 | 0.5 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.2 | 1.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 2.6 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.2 | 0.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 1.0 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.2 | 0.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 3.2 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.2 | 6.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 1.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 0.7 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 2.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.2 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.2 | 1.0 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.2 | 0.2 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.2 | 3.0 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 0.7 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.3 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.2 | 1.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.5 | GO:0097272 | ammonia homeostasis(GO:0097272) |
0.2 | 2.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.2 | 0.2 | GO:0001300 | chronological cell aging(GO:0001300) |
0.2 | 1.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.2 | 0.6 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.2 | 0.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 6.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 3.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 1.2 | GO:0045007 | depurination(GO:0045007) |
0.2 | 0.3 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 0.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 2.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 2.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 2.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.5 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.2 | 0.8 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 0.5 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.2 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.2 | 0.5 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.5 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.2 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.6 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.4 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.1 | 0.3 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 0.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.6 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.1 | 10.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 0.7 | GO:0035900 | response to isolation stress(GO:0035900) |
0.1 | 2.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.4 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
0.1 | 0.1 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.1 | 1.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 1.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 1.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 39.7 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.7 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.7 | GO:0046077 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
0.1 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 9.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.1 | 0.7 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.3 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.4 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 12.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.4 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.1 | 0.4 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.1 | 1.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 3.7 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.1 | 0.5 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.1 | 0.9 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.3 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) negative regulation of bone mineralization involved in bone maturation(GO:1900158) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.1 | 1.6 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.1 | 0.4 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.1 | 0.3 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.1 | 1.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 1.2 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 1.3 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 0.9 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.1 | 1.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 1.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.5 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.4 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.1 | 1.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.4 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.1 | 2.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.4 | GO:0021503 | neural fold bending(GO:0021503) |
0.1 | 3.6 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.9 | GO:0010816 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 1.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.4 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
0.1 | 0.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 2.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 1.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.1 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 1.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 2.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 1.5 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 2.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.3 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.1 | 1.6 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 1.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.3 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.4 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 17.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.1 | GO:0061227 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
0.1 | 0.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 1.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 1.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 1.0 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.4 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
0.1 | 0.5 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.1 | 0.6 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.3 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.1 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.4 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.7 | GO:2000814 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.1 | 3.1 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 2.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.3 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 1.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 1.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:0090340 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
0.1 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.6 | GO:0070378 | positive regulation of ERK5 cascade(GO:0070378) |
0.1 | 2.0 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 1.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 2.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.3 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.1 | 1.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 1.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.5 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.1 | 0.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.3 | GO:0007174 | epidermal growth factor catabolic process(GO:0007174) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.1 | 0.3 | GO:0005999 | xylulose biosynthetic process(GO:0005999) |
0.1 | 0.1 | GO:0090164 | protein retention in Golgi apparatus(GO:0045053) asymmetric Golgi ribbon formation(GO:0090164) |
0.1 | 0.6 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.1 | 0.3 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.5 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
0.1 | 0.7 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.6 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.1 | 0.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.9 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.3 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.3 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 1.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.0 | GO:0072505 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.1 | 0.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.8 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
0.1 | 1.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 1.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 1.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.5 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
0.1 | 3.6 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 0.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.2 | GO:0060364 | uterine wall breakdown(GO:0042704) frontal suture morphogenesis(GO:0060364) |
0.1 | 0.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.1 | 0.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.4 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.1 | 0.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.9 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 1.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.3 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 0.2 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
0.1 | 0.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.3 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.1 | 0.4 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.6 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.2 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.1 | 0.2 | GO:1903452 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.1 | 1.2 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 0.9 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 1.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 1.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.4 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.2 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 0.4 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.9 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.2 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.1 | 4.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.3 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.5 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 0.7 | GO:0042092 | type 2 immune response(GO:0042092) |
0.1 | 0.4 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 6.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 0.7 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 0.7 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.1 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.1 | 0.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 2.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.1 | 0.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.1 | 5.1 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.1 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 1.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.2 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.1 | 0.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 1.2 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
0.1 | 0.3 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
0.1 | 0.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.2 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.1 | 0.2 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 1.0 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.6 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 6.3 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.1 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.2 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.7 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.1 | 1.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.2 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 41.4 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.1 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 0.4 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.1 | 0.6 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 1.4 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.8 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 1.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.4 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.1 | 3.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.4 | GO:0046066 | dGDP metabolic process(GO:0046066) |
0.1 | 6.0 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.4 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.1 | 0.1 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.1 | 1.6 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.1 | 1.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.5 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.5 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 1.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.5 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.2 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.1 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.1 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 2.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.5 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 0.2 | GO:0097086 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
0.1 | 0.1 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.1 | 0.3 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.1 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.4 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.1 | 0.1 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.1 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 2.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.2 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.1 | 0.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 0.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.1 | 2.1 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.1 | 0.1 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.1 | 0.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 1.7 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.2 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.1 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 1.8 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 1.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.3 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.5 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.3 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.0 | 0.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.0 | 0.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 2.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.2 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.2 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.0 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.2 | GO:0072560 | type B pancreatic cell maturation(GO:0072560) |
0.0 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.1 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 0.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.0 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.0 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.1 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.0 | 0.0 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.0 | 1.1 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.6 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.0 | 0.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.1 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.0 | 0.4 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.7 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.8 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.1 | GO:0070377 | negative regulation of ERK5 cascade(GO:0070377) |
0.0 | 0.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.3 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.7 | GO:0019081 | viral translation(GO:0019081) |
0.0 | 0.2 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.0 | 0.0 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.0 | 0.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 1.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.2 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.2 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.2 | GO:0046778 | modulation by virus of host gene expression(GO:0039656) modification by virus of host mRNA processing(GO:0046778) |
0.0 | 0.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.0 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.0 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
0.0 | 0.1 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
0.0 | 0.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
0.0 | 0.1 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
0.0 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.5 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.6 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.0 | 0.3 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.0 | 0.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.2 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.0 | 0.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.4 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.5 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.5 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.3 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.0 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.6 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.0 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.0 | 0.1 | GO:1903576 | response to L-arginine(GO:1903576) |
0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.3 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 1.6 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 1.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 1.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.0 | 2.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.0 | 1.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.2 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.0 | 2.7 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.1 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.0 | 2.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.5 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.2 | GO:0060356 | leucine import(GO:0060356) |
0.0 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 0.1 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.0 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.0 | 0.6 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.1 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.0 | 0.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.0 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.0 | 0.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.0 | 0.3 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 3.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 1.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 1.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.2 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.0 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.1 | GO:0048561 | establishment of organ orientation(GO:0048561) |
0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.2 | GO:1903298 | negative regulation of cellular response to hypoxia(GO:1900038) regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.0 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.1 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.0 | 0.1 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.3 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.3 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.8 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.1 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.0 | 0.5 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.0 | 0.8 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.0 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.1 | GO:0035909 | aorta morphogenesis(GO:0035909) |
0.0 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.3 | GO:0098969 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.0 | 0.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.3 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.0 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.0 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.0 | 1.0 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.0 | 0.0 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.0 | 0.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.2 | GO:0090220 | meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.3 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.9 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.0 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.0 | GO:1905045 | Schwann cell proliferation involved in axon regeneration(GO:0014011) Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.0 | 0.1 | GO:0014854 | response to inactivity(GO:0014854) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.0 | GO:0035498 | carnosine metabolic process(GO:0035498) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.0 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 7.8 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) dimeric IgA immunoglobulin complex(GO:0071750) secretory IgA immunoglobulin complex(GO:0071751) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
2.1 | 10.5 | GO:0071754 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
1.3 | 6.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
1.3 | 4.0 | GO:0036284 | tubulobulbar complex(GO:0036284) |
1.2 | 62.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.2 | 3.6 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
1.2 | 3.5 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
1.0 | 4.8 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.8 | 8.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.8 | 1.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.8 | 2.4 | GO:0032473 | cytoplasmic side of mitochondrial outer membrane(GO:0032473) caveola neck(GO:0099400) |
0.8 | 9.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.7 | 7.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 4.9 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 4.8 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.6 | 2.9 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.6 | 10.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.6 | 7.8 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.5 | 2.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.5 | 5.8 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.5 | 18.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 2.3 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.4 | 9.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 4.8 | GO:0042612 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.4 | 3.0 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 2.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 7.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 3.6 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 1.5 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.4 | 3.0 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 15.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.0 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.3 | 2.3 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 0.9 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.3 | 5.1 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 1.7 | GO:0036398 | TCR signalosome(GO:0036398) |
0.3 | 1.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.3 | 17.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.3 | 4.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 1.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 2.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 0.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.7 | GO:1990332 | Ire1 complex(GO:1990332) |
0.2 | 0.7 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.2 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.9 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.9 | GO:1990879 | CST complex(GO:1990879) |
0.2 | 5.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 2.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.4 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.2 | 0.6 | GO:0032116 | SMC loading complex(GO:0032116) |
0.2 | 1.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 0.6 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 2.0 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.2 | 0.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 2.4 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 21.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 1.8 | GO:0061702 | inflammasome complex(GO:0061702) |
0.2 | 3.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 3.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 2.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 1.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 5.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.7 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.6 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.2 | 1.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 3.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.8 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.2 | 0.6 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.2 | 0.5 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.2 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 1.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 1.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 22.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 1.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.7 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.6 | GO:0030892 | mitotic cohesin complex(GO:0030892) |
0.1 | 11.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.9 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 0.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.1 | 2.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 52.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.3 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.1 | 26.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 1.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.9 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 2.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.1 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.1 | 1.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 9.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 4.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 1.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 3.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 8.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.6 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 2.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.5 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
0.1 | 0.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 2.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.3 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.1 | 1.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 8.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.3 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.1 | 0.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.3 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 6.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.3 | GO:0090651 | apical cytoplasm(GO:0090651) |
0.1 | 6.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 2.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.4 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 20.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 9.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 0.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 1.0 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 5.3 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.4 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 0.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 1.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.1 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.1 | 0.3 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.1 | 1.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 2.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.2 | GO:0097196 | Shu complex(GO:0097196) |
0.1 | 0.6 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.4 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 0.3 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 0.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 1.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 8.5 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 9.9 | GO:0016605 | PML body(GO:0016605) |
0.1 | 8.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 1.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.0 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 3.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 9.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
0.0 | 1.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 2.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.2 | GO:0002133 | polycystin complex(GO:0002133) |
0.0 | 21.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 1.9 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.0 | 1.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 1.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 1.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 2.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 2.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 3.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 1.1 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0070701 | mucus layer(GO:0070701) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 4.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 5.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 1.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 1.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.0 | 40.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 2.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.9 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 1.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0043601 | nuclear replisome(GO:0043601) |
0.0 | 0.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 6.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
1.3 | 4.0 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
1.2 | 5.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.2 | 84.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.0 | 224.5 | GO:0003823 | antigen binding(GO:0003823) |
1.0 | 3.0 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.9 | 4.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.9 | 7.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.8 | 3.3 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.8 | 2.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) peroxidase inhibitor activity(GO:0036479) |
0.8 | 2.4 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
0.7 | 7.3 | GO:0019863 | IgE binding(GO:0019863) |
0.7 | 3.5 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.6 | 9.1 | GO:0019864 | IgG binding(GO:0019864) |
0.6 | 1.9 | GO:0005369 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.6 | 3.7 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.6 | 2.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.6 | 2.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.6 | 2.3 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.6 | 1.7 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
0.5 | 2.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.5 | 2.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 2.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.5 | 1.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 11.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.5 | 3.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 4.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 2.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.5 | 1.9 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.5 | 0.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 2.7 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.4 | 1.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.4 | 1.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.4 | 1.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.4 | 1.7 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.4 | 3.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.4 | 4.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 4.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 2.7 | GO:0042806 | fucose binding(GO:0042806) |
0.4 | 3.8 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.4 | 3.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.4 | 5.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 2.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 2.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 5.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.4 | 4.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 1.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.4 | 1.1 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.4 | 1.1 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.3 | 7.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 1.0 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.3 | 1.3 | GO:0045569 | TRAIL binding(GO:0045569) |
0.3 | 2.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 1.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 2.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.3 | 2.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.2 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.3 | 2.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 1.2 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.3 | 6.6 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 2.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 1.1 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.3 | 1.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.3 | 1.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.3 | 1.1 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.3 | 0.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.3 | 0.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 5.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 2.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 0.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.7 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.2 | 1.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 1.0 | GO:0043273 | CTPase activity(GO:0043273) |
0.2 | 0.7 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.2 | 0.7 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.2 | 1.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 2.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 4.5 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 1.6 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.2 | 0.7 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.2 | 1.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.9 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.2 | 1.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.9 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 2.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.7 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.2 | 10.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 2.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.7 | GO:0005139 | interleukin-7 receptor binding(GO:0005139) |
0.2 | 2.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 1.1 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.2 | 1.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 2.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.2 | 12.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 3.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 4.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.6 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.2 | 1.0 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.2 | 1.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.2 | 0.6 | GO:0035375 | zymogen binding(GO:0035375) |
0.2 | 1.0 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.2 | 0.6 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
0.2 | 19.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.8 | GO:0008832 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
0.2 | 2.0 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.2 | 6.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.9 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.4 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.2 | 0.5 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.2 | 1.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.2 | 6.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.0 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.2 | 0.5 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
0.2 | 1.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.2 | 1.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 1.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 5.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 7.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 1.6 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 1.0 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.2 | 8.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 1.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 3.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 0.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 1.7 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.8 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.4 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 0.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 2.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 1.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 7.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.7 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.1 | 0.6 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.1 | 1.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 2.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 2.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
0.1 | 0.7 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.1 | 1.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 0.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.7 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.4 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.5 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.1 | 0.3 | GO:0047977 | linoleate 13S-lipoxygenase activity(GO:0016165) hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.1 | 1.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 1.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 1.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 1.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.5 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.1 | 1.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 4.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.1 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.4 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.1 | 2.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.7 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.6 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 5.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.3 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.6 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 0.3 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
0.1 | 1.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.3 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.1 | 0.6 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
0.1 | 0.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 6.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.8 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.1 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.4 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 2.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 2.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0031692 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.1 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 1.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 7.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.7 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 3.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.3 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.1 | 0.7 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.1 | 0.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 1.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.4 | GO:0004641 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
0.1 | 0.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 3.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.3 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.1 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.4 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 0.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 1.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 2.6 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 1.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.4 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.3 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.1 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.2 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.3 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.1 | 2.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.3 | GO:0070224 | sulfide:quinone oxidoreductase activity(GO:0070224) |
0.1 | 1.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 7.4 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 1.8 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.2 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
0.1 | 0.2 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 0.3 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.1 | 0.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.5 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.6 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.1 | 0.3 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.1 | 2.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.5 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.4 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.1 | 1.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 1.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.2 | GO:0035731 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
0.1 | 0.3 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.1 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.1 | 0.3 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.2 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.1 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 1.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 4.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 2.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.2 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 6.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.2 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 2.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.4 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 0.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 1.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 2.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 0.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 0.6 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.5 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 2.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 2.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.6 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.8 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 3.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 1.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.0 | 9.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.0 | 0.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.4 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 1.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 1.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.0 | 3.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.0 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.0 | 22.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.0 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 1.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 2.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 1.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 1.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0044714 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
0.0 | 0.0 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.0 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 2.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 1.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.0 | 0.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
0.0 | 8.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 4.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 1.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 1.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.3 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.3 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.0 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.0 | 1.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.6 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 1.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.0 | 0.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 11.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 1.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 1.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.5 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.0 | 4.1 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
0.0 | 4.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.2 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.0 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.1 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.0 | 1.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.7 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 1.2 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 8.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.0 | 1.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.6 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.0 | 2.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.0 | GO:0017129 | triglyceride binding(GO:0017129) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.0 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.0 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.0 | 0.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.3 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.6 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 3.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 17.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 49.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 15.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 0.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 11.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 9.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 9.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 2.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 28.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 6.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 13.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 3.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 4.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 10.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 2.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 5.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 4.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 4.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 1.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 5.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 10.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 0.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 3.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 5.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 9.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 3.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 5.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 8.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 5.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 3.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 4.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 2.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 5.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 4.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.9 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 4.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 2.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 8.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 2.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 3.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 7.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 15.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 1.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 3.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 3.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 3.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 1.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 2.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 2.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 1.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 2.1 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 8.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 2.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 15.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.7 | 7.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 10.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 3.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 41.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 5.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 1.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 8.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 24.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 9.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 17.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 2.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 1.5 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.2 | 0.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 2.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 0.2 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.2 | 6.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 0.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 7.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 10.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 6.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 6.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 4.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 16.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 3.6 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 1.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 2.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 9.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 4.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.7 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 3.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 6.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 18.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 2.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 5.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 3.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.7 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 1.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 5.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 3.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 2.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.9 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 3.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 3.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 3.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 3.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 1.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 3.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 3.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 2.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 3.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 3.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 6.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 1.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 1.2 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 2.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 1.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 10.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 7.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 1.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 1.1 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 2.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 3.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 2.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.7 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.4 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.4 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 1.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |